This event has finished
Abstracts oral / poster presentations
BHS Board 2012 annual report
Slides invited speakers:
Special highlight 1: Treatment of chronic myeloid malignancies
Therapeutic approach to myelofibrosis in the JAK2 inhibitor era - A. Vannucchi (Florence, Italy) (supported by an unrestricted grant from Novartis)
State-of-the-art lectures
Epigenetic regulation of hematological malignancies - E. De Bruyne (Brussels)
Regulatory T-cells - S. Humblet (Liège & Leuven)
Pierre Strijckmans lecture
N/A Angiogenesis, also in leukemia - P. Carmeliet (Leuven)
Special highlight 2: Non-malignant hematology
Macrophage activation syndromes - C. Larroche (Avicenne, France)
Ribosome dysfunction as a cause of bone marrow failure - B. Ebert (Boston, USA)
Special highlight 3: Chronic lymphocytic leukemia
Biology - P. Ghia (Milano, Italy)
Treatment - T. Robak (Lodz, Poland)
Transplantation - P. Dreger (Heidelberg, Germany)